Montelukast Tablet
Montelukast is a compounded formulation containing Montelukast, prepared by Mixlab for veterinary use. Available by prescription.
The uses and pharmacology described below reflect the FDA-approved labeling for this active ingredient; your veterinarian determines whether and how they apply to your animal's treatment plan.
Montelukast sodium is a leukotriene receptor antagonist utilized in veterinary medicine for its ability to influence localized inflammatory responses. It is a prescription medication available for use in dogs and cats, frequently considered by veterinarians for patients presented with respiratory health challenges or environmental sensitivities. Your veterinarian will determine the clinical appropriateness of this medication based on your pet's diagnostic findings.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring. Compounded drugs are not approved by the FDA for safety or effectiveness.
At a pharmacological level, it is considered to influence the physiological response to leukotrienes, which are mediators involved in airway constriction and inflammation. Commonly observed effects are typically rare but may include localized digestive changes such as vomiting or behavioral shifts like temporary restlessness. Owners should monitor for any unusual changes in energy or appetite and contact their veterinarian promptly. It is typically evaluated carefully in patients with known severe hepatic impairment.
Yes. Montelukast is a prescription medication and requires a valid authorization from a licensed veterinarian. Mixlab verifies all legal and professional requirements before preparing any medication.
Yes. Mixlab specializes in compounding montelukast into customized strengths and flavored oral formats, such as flavored oral liquids or treats, to support easier administration for your pet.
Veterinarians discuss montelukast because it is considered to influence the receptors that may contribute to airways tightening and swelling in response to triggers. This provides a method for addressing respiratory comfort during recovery.
No. Montelukast is a leukotriene receptor antagonist, which is a different class of medication than corticosteroids. Your veterinarian will determine if it is the right approach for your pet's specific inflammatory needs.
You should monitor for observational signs like easier breathing and a decrease in coughing or sneezing. Your veterinarian will provide a specific monitoring schedule for your pet's management plan.
